These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29559645)

  • 21. ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function.
    Sharma A; Lyashchenko AK; Lu L; Nasrabady SE; Elmaleh M; Mendelsohn M; Nemes A; Tapia JC; Mentis GZ; Shneider NA
    Nat Commun; 2016 Feb; 7():10465. PubMed ID: 26842965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Overexpression of TDP-43 Protein in the Neuron and Oligodendrocyte Cells Causes the Progressive Motor Neuron Degeneration in the SOD1 G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
    Lu Y; Tang C; Zhu L; Li J; Liang H; Zhang J; Xu R
    Int J Biol Sci; 2016; 12(9):1140-9. PubMed ID: 27570488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of TDP-43 causes age-dependent progressive motor neuron degeneration.
    Iguchi Y; Katsuno M; Niwa J; Takagi S; Ishigaki S; Ikenaka K; Kawai K; Watanabe H; Yamanaka K; Takahashi R; Misawa H; Sasaki S; Tanaka F; Sobue G
    Brain; 2013 May; 136(Pt 5):1371-82. PubMed ID: 23449777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.
    Niessen HG; Angenstein F; Sander K; Kunz WS; Teuchert M; Ludolph AC; Heinze HJ; Scheich H; Vielhaber S
    Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Degeneration of axons in spinal white matter in G93A mSOD1 mouse characterized by NFL and α-internexin immunoreactivity.
    King AE; Blizzard CA; Southam KA; Vickers JC; Dickson TC
    Brain Res; 2012 Jul; 1465():90-100. PubMed ID: 22609817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calpastatin inhibits motor neuron death and increases survival of hSOD1(G93A) mice.
    Rao MV; Campbell J; Palaniappan A; Kumar A; Nixon RA
    J Neurochem; 2016 Apr; 137(2):253-65. PubMed ID: 26756888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
    Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
    Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel mouse model with impaired dynein/dynactin function develops amyotrophic lateral sclerosis (ALS)-like features in motor neurons and improves lifespan in SOD1-ALS mice.
    Teuling E; van Dis V; Wulf PS; Haasdijk ED; Akhmanova A; Hoogenraad CC; Jaarsma D
    Hum Mol Genet; 2008 Sep; 17(18):2849-62. PubMed ID: 18579581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of collapsin response mediator protein-2 phosphorylation ameliorates motor phenotype of ALS model mice expressing SOD1G93A.
    Numata-Uematsu Y; Wakatsuki S; Nagano S; Shibata M; Sakai K; Ichinohe N; Mikoshiba K; Ohshima T; Yamashita N; Goshima Y; Araki T
    Neurosci Res; 2019 Feb; 139():63-68. PubMed ID: 30194029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identifying the primary site of pathogenesis in amyotrophic lateral sclerosis - vulnerability of lower motor neurons to proximal excitotoxicity.
    Blizzard CA; Southam KA; Dawkins E; Lewis KE; King AE; Clark JA; Dickson TC
    Dis Model Mech; 2015 Mar; 8(3):215-24. PubMed ID: 25740331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TDP-43 in differential diagnosis of motor neuron disorders.
    Dickson DW; Josephs KA; Amador-Ortiz C
    Acta Neuropathol; 2007 Jul; 114(1):71-9. PubMed ID: 17569066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of mutant superoxide dismutase 1 causes a motor axonopathy in the zebrafish.
    Lemmens R; Van Hoecke A; Hersmus N; Geelen V; D'Hollander I; Thijs V; Van Den Bosch L; Carmeliet P; Robberecht W
    Hum Mol Genet; 2007 Oct; 16(19):2359-65. PubMed ID: 17636250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. VAChT overexpression increases acetylcholine at the synaptic cleft and accelerates aging of neuromuscular junctions.
    Sugita S; Fleming LL; Wood C; Vaughan SK; Gomes MP; Camargo W; Naves LA; Prado VF; Prado MA; Guatimosim C; Valdez G
    Skelet Muscle; 2016; 6():31. PubMed ID: 27713817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice.
    Wong M; Martin LJ
    Hum Mol Genet; 2010 Jun; 19(11):2284-302. PubMed ID: 20223753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropathologic and biochemical changes during disease progression in liver X receptor beta-/- mice, a model of adult neuron disease.
    Bigini P; Steffensen KR; Ferrario A; Diomede L; Ferrara G; Barbera S; Salzano S; Fumagalli E; Ghezzi P; Mennini T; Gustafsson JA
    J Neuropathol Exp Neurol; 2010 Jun; 69(6):593-605. PubMed ID: 20467332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamic neuromuscular remodeling precedes motor-unit loss in a mouse model of ALS.
    Martineau É; Di Polo A; Vande Velde C; Robitaille R
    Elife; 2018 Oct; 7():. PubMed ID: 30320556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tardbpl splicing rescues motor neuron and axonal development in a mutant tardbp zebrafish.
    Hewamadduma CA; Grierson AJ; Ma TP; Pan L; Moens CB; Ingham PW; Ramesh T; Shaw PJ
    Hum Mol Genet; 2013 Jun; 22(12):2376-86. PubMed ID: 23427147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spinal inhibitory interneuron pathology follows motor neuron degeneration independent of glial mutant superoxide dismutase 1 expression in SOD1-ALS mice.
    Hossaini M; Cardona Cano S; van Dis V; Haasdijk ED; Hoogenraad CC; Holstege JC; Jaarsma D
    J Neuropathol Exp Neurol; 2011 Aug; 70(8):662-77. PubMed ID: 21760539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced VGLUT2 expression increases motor neuron viability in Sod1(G93A) mice.
    Wootz H; Enjin A; Wallén-Mackenzie A; Lindholm D; Kullander K
    Neurobiol Dis; 2010 Jan; 37(1):58-66. PubMed ID: 19770042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of independent screens on differentially vulnerable motor neurons reveals alpha-synuclein as a common modifier in motor neuron diseases.
    Kline RA; Kaifer KA; Osman EY; Carella F; Tiberi A; Ross J; Pennetta G; Lorson CL; Murray LM
    PLoS Genet; 2017 Mar; 13(3):e1006680. PubMed ID: 28362802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.